The <i>IGF2</i> intronic miR-483 selectively enhances transcription from <i>IGF2</i> fetal promoters and enhances tumorigenesis
Mingzhu Liu(Howard Hughes Medical Institute), Daniel A. Haber(Howard Hughes Medical Institute), Jun Lü(Yale Cancer Center), Francesca Bersani(Ospedale San Luigi Gonzaga), Shobha Vasudevan(Harvard University), Miguel N. Rivera(University of North Texas), Min Yu(Howard Hughes Medical Institute), Anna Roth(German Cancer Research Center), Sven Diederichs(German Cancer Research Center), Shyamala Maheswaran(Massachusetts General Hospital), Toshi Shioda(Center for Cancer Research), Sridhar Ramaswamy(Harvard University), Robert Morris(Massachusetts General Hospital)
Cited by 150
Related Papers
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
|Cell|2004|3.8k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
|Endocrine Reviews|2012|3.1k